Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients-real-world data.

Polkowska M, Ekk-Cierniakowski P, Czepielewska E, Kozłowska-Wojciechowska M.

Eur J Clin Pharmacol. 2019 Mar;75(3):329-334. doi: 10.1007/s00228-018-2590-6. Epub 2018 Nov 1.

PMID:
30386910
2.

Drug adulteration of food supplements: A threat to public health in the European Union?

Czepielewska E, Makarewicz-Wujec M, Różewski F, Wojtasik E, Kozłowska-Wojciechowska M.

Regul Toxicol Pharmacol. 2018 Aug;97:98-102. doi: 10.1016/j.yrtph.2018.06.014. Epub 2018 Jun 19.

PMID:
29932980
3.

SOX10-MITF pathway activity in melanoma cells.

Tudrej KB, Czepielewska E, Kozłowska-Wojciechowska M.

Arch Med Sci. 2017 Oct;13(6):1493-1503. doi: 10.5114/aoms.2016.60655. Epub 2016 Jun 17.

4.

Survival of melanoma patients treated with novel drugs: retrospective analysis of real-world data.

Polkowska M, Ekk-Cierniakowski P, Czepielewska E, Wysoczański W, Matusewicz W, Kozłowska-Wojciechowska M.

J Cancer Res Clin Oncol. 2017 Oct;143(10):2087-2094. doi: 10.1007/s00432-017-2453-z. Epub 2017 Jun 12.

PMID:
28608286
5.

Uncaria tomentosa Leaves Decoction Modulates Differently ROS Production in Cancer and Normal Cells, and Effects Cisplatin Cytotoxicity.

Kośmider A, Czepielewska E, Kuraś M, Gulewicz K, Pietrzak W, Nowak R, Nowicka G.

Molecules. 2017 Apr 12;22(4). pii: E620. doi: 10.3390/molecules22040620.

6.

Drug Combinations as the New Standard for Melanoma Treatment.

Polkowska M, Czepielewska E, Kozłowska-Wojciechowska M.

Curr Treat Options Oncol. 2016 Dec;17(12):61. Review.

PMID:
27766547

Supplemental Content

Loading ...
Support Center